已更新
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
传染病学 2025医学知识库
临床指南
查阅医学学会和卫生主管部门发布的官方指南、共识文件及更新信息。
官方可靠来源医学学会和卫生主管部门
信息持续更新持续开展科学监测
面向专业人士免费开放服务于医学界
重要出版物和更新
查看最新发布内容
已更新
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
心脏病学 2025
官方发布
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
儿科学 2026所有指南 (126 个结果)
筛选条件
Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovi...
Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]”. NACI recommend...
Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 v...
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recomme...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax CO...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]”. NACI i...
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]”. NACI up...